Pathotrak
PrivateLast Round
Debt
Sep 4, 2025
Total Funding Raised
$5.36M
Company Overview
Pathotrak operates in Healthcare & Life Sciences and is based in Laurel, Maryland. Its latest recorded funding round was a VC Round in February 2025.
Pathotrak is a biotechnology company that has developed a sample-prep kit to expedite the detection of foodborne pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Quality Management
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathotrak Comparables
Compare Pathotrak with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yarok Microbio | 79% | |
| SnapDNA | 78% | |
| PathogenDx | 71% |
For institutional investors. Book with your work email.
Pathotrak Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 4, 2025 | ||||
| VC Round | Feb 25, 2025 | ||||
| Series A | Dec 1, 2023 | ||||
| VC Round | May 23, 2023 | ||||
| Grant | Jan 27, 2022 | ||||
Seed | May 18, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pathotrak Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dingman Center Angels | Seed |
| TEDCO | Seed, Grant, VC Round |
| University System of Maryland Momentum Fund | Seed |
| University of Maryland, Baltimore | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 641% MoM, reaching 2.6K.
- Sep 4, 2025
$2.2M debt round raised.
For institutional investors. Book with your work email.
Pathotrak Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pathotrak's valuation, stock price, and market status.
Is Pathotrak a public or private company?
Pathotrak is a private company.
What is the current stock price of Pathotrak?
Pathotrak is a private company, so its shares have no public market price. Caplight tracks Pathotrak's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pathotrak worth (valuation)?
Valuation information for Pathotrak is not publicly available.
Can I buy Pathotrak stock?
Pathotrak shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pathotrak's last funding round?
Pathotrak's most recent funding round was Debt on September 4, 2025.
Who are the main investors in Pathotrak?
Key investors in Pathotrak include TEDCO.
Will Pathotrak IPO soon?
No public IPO plans have been announced for Pathotrak.
How can I track Pathotrak secondary market activity?
Caplight tracks bids, offers, and trades in Pathotrak's shares on secondary markets.